logo

DARE

Dare Bioscience·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

DARE fundamentals

Dare Bioscience (DARE) released its earnings on Nov 13, 2025: revenue was 2.26K (YoY -94.57%), missed estimates; EPS was -0.28 (YoY +49.09%), beat estimates.
Revenue / YoY
2.26K
-94.57%
EPS / YoY
-0.28
+49.09%
Report date
Nov 13, 2025
DARE Earnings Call Summary for Q3,2025
  • Commercial Milestone: DARE to PLAY Sildenafil Cream launched Q4 2025 via 503B, targeting $1.2B women's sexual health market.
  • Pipeline Progress: Phase III Ovaprene contraceptive trial on track for 2026 completion; DARE-HPV intravaginal therapy IND filing underway.
  • Financial Strength: $23M cash, $31M+ grants fund R&D; 503B launches position for near-term revenue.
  • FDA Strategy: Dual-path approach for DARE to RECLAIM hormone therapy (503B Q1 2027 + FDA) capitalizes on FDA policy shift.
EPS
Revenue

Revenue & Expenses

DARE has released its 2025 Q3 earnings report, with revenue of 2.26K, reflecting a YoY change of -94.57%, and net profit of -3.56M, showing a YoY change of 24.24%. The Sankey diagram below clearly presents DARE's revenue sources and cost distribution.

Key Indicators

Dare Bioscience (DARE) key financial stats and ratios, covering profitability, financial health, and leverage.
Dare Bioscience (DARE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Dare Bioscience (DARE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Dare Bioscience (DARE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Dare Bioscience (DARE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Dare Bioscience (DARE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield